Media and Press

iMedicor Announces Partnership with PhoneTag for Interoperable Handheld Transcription Services for the Healthcare Community

Services Intended for use with the iPhone and all Other Smart Phone Devices via iMedicor's HIPAA Compliant Portal

Nanuet, NY, August 25, 2009 - iMedicor (OTCBB: VMCI) today announced it has entered into a partnership with PhoneTag, the leader in voicemail-to-text services and visual voicemail applications. Through this partnership, physicians and healthcare providers will have access to transcription services on their mobile device of choice. The basic service will be free to all users with a premium monthly subscription upgrade available.

PhoneTag, the leader in the voicemail-to-text space, offers breakthrough technology that enables users to reduce the time needed to listen to voicemail by having messages converted to text. The Company, founded in 2003 and previously known as SimulScribe, has experienced tremendous growth and success by offering the highest quality voicemail-to-text services.

"We are pleased to solidify our relationship with PhoneTag and look forward to making their cutting-edge transcription services available to physicians and healthcare providers via iMedicor's secure portal," said Fred Zolla, CEO of iMedicor. "With the addition of voice activated transcription capabilities, we continue to build our unique suite of services that offer a new, attainable level of efficiency for physicians."

iMedicor is the first free, HIPAA compliant health information exchange portal, offering a proprietary technology solution that addresses the long-standing and widespread inability of disparate Electronic Medical Records (EMR) systems to communicate, collaborate and exchange medical records in a HIPAA compliant environment.

"This partnership combines PhoneTag's award winning transcription capabilities with iMedicor's unparallel group of solutions for physicians that streamline workflow and increase cost savings for the medical community" said James Siminoff, CEO of PhoneTag. "We are proud to join iMedicor in adapting technology to meet the needs of the healthcare community."

About iMedicor:

iMedicor is the only HIPAA-compliant solution for interoperable health information transfer that is offered at no cost to physicians, healthcare providers and patients. The iMedicor portal enables disparate EMR (electronic medical record) systems to communicate, collaborate and exchange records in real time; pharmaceutical companies to deliver customized educational marketing programs to more than 730,000 healthcare providers nationwide in a highly targeted, non-intrusive manner; and allows a medical practice to send and receive medical records, files and images. For more information on iMedicor visit www.imedicor.com.

About PhoneTag:

PhoneTag's award winning service enables users to read their voicemail, saving time and money. Users can unify all phone numbers for automatic transcription and delivery without changing any phone numbers. PhoneTag provides unlimited voicemail storage and has a transcription accuracy of over 95 percent. PhoneTag's service works with all wireless and wire-line network providers, including AT&T, Alltel, Cincinnati Bell, Sprint, Skype, T-Mobile, Verizon, Virgin, Rogers and over 50 more. New users can sign up at www.PhoneTag.com. PhoneTag is based in New York, N.Y.

The statements contained herein, other than historical information, are or may be deemed to be forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance of iMedicor’s products and services; the nonexclusive and terminable-at-will nature of certain of the company's partnerships and agreements; rapid technological change affecting demand for our products and services; competition from companies providing similar products and services, availability of sufficient financial resources to enable us to expand our operations, as well as other risks detailed from time to time in our filing s with the Securities and Exchange Commission.